Europe Obesity Treatment Market

Published Apr 01, 2025

Length 350 Pages

SKU # DAABD20406819

Description

Europe obesity treatment market is expected to reach USD 21.38 million by 2032 from USD 7.48 million in 2024, growing at a CAGR of 14.0% in the forecast period of 2025 to 2032.
Market Segmentation:
Europe Obesity Treatment Market, Treatment Type (Pharmacological Treatments (Anti-obesity Drugs), Bariatric Surgery, Behavioral & Lifestyle Therapy, Non-Invasive/ Endoscopic Procedures, and Medical Devices & Technologies), Age Group (Adult Obesity Treatment, Geriatric Obesity Treatment, and Pediatric Obesity Treatment), Distribution Channel (Online Pharmacies, Retail Pharmacies, Weight Management Clinics, Hospital Pharmacies, and Wellness & Fitness Centers), Patient Type (Class III, Class II, and Class I), Country (Germany, U.K., France, Russia, Italy, Spain, Turkey, Poland, Netherlands, Switzerland, Norway, Austria, Ireland, and Rest of Europe) - Industry Trends and Forecast to 2032

Overview of Europe Obesity Treatment market Dynamics:

Driver

• Integration of Digital Health Solutions in Obesity Treatment

Restraint

• Anti-Obesity Drugs and Surgical Interventions Carry Risks

Opportunity

• Increasing Prevalence of Lifestyle Related Diseases

Market Players:

The key market players operating in the Europe obesity treatment market are listed below:

• Novo Nordisk A/S
• Eli Lilly and Company
• Medtronic Plc.
• Boston Scientific Corporation
• Johnson & Johnson Services, Inc.
• AstraZeneca
• Sanofi
• Allurion Technologies
• GSK plc
• F. HOFFMANN LA-ROCHE AG

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.

1 Introduction: 1.1 Objectives Of The Study; 1.2 Market Definition; 1.3 Overview Of The Europe Obesity Treatment Market; 1.4 Currency And Pricing; 1.5 Limitations; 1.6 Markets Covered
2 Market Segmentation: 2.1 Markets Covered; 2.2 Geographical Scope; 2.3 Years Considered For The Study; 2.4 Dbmr Tripod Data Validation Model; 2.5 Multivariate Modelling; 2.6 Treatment Type Lifeline Curve; 2.7 Primary Interviews With Key Opinion Leaders; 2.8 Dbmr Market Position Grid; 2.9 Market End User Coverage Grid; 2.10 Vendor Share Analysis; 2.11 Secondary Sources; 2.12 Assumptions
3 Executive Summary
4 Premium Insights: 4.1 Porter’s Five Forces; 4.2 Pestel Analysis; 4.3 Epidemiology: Europe Obesity Treatment Market; 4.4 Drug Treatment Rate By Matured Markets: Europe Obesity Treatment Market; 4.5 Drug; 4.6 Word Pipeline
5 Regulatory Framework For The Europe Obesity Treatment Market: 5.1 Regulatory Approval Pathways; 5.2 Licensing And Registration; 5.3 Regulatory Approval Pathways; 5.4 Licensing And Registration; 5.5 Good Manufacturing Practices (Gmps) Guidelines
6 Market Overview: 6.1 Drivers; 6.1.1 Increasing Prevalence Of Obesity; 6.1.2 Innovations In Anti-obesity Medications; 6.1.3 Growth In Bariatric And Metabolic Surgeries.; 6.1.4 Integration Of Digital Health Solutions In Obesity Treatment; 6.2 Restraints; 6.2.1 Anti-obesity Drugs And Surgical Interventions Carry Risks; 6.2.2 High Relapse Rates Post-treatment Of Obesity; 6.3 Opportunities; 6.3.1 Increasing Prevalence Of Lifestyle Related Diseases; 6.3.2 Rising Disposable Income Enhancing The Purchasing Power For Obesity Treatment Related Products; 6.3.3 Rise In Strategic Initiatives And Launches By Market Players; 6.4 Challenges; 6.4.1 Long-term Follow-ups Associated With Obesity Treatment; 6.4.2 Addressal Of The Lifestyle And Behavioral Changes
7 Europe Obesity Treatment Market, By Treatment Type: 7.1 Overview; 7.2 Pharmacological Treatments (Anti-obesity Drugs); 7.2.1 Glp-1 Receptor Agonists; 7.2.2 Dual Gip/ Glp-1 Receptor Agonists; 7.2.2.1 Phentermine; 7.2.2.2 Phentermine-topiramate; 7.2.2.3 Naltrexone-bupropion; 7.2.3 Lipase Inhibitors; 7.2.4 Deoxycholic Acid; 7.2.5 Others; 7.3 Bariatric Surgery; 7.3.1 Restrictive Surgeries; 7.3.1.1 Sleeve Gastrectomy; 7.3.1.2 Adjustable Gastric Banding; 7.3.2 Combination Surgeries; 7.3.2.1 Roux-en-y Gastric Bypass (Rygb); 7.3.2.2 Mini-gastric Bypass (Mgb); 7.3.3 Malabsorptive Surgeries; 7.3.3.1 Laparoscopic Surgery; 7.3.3.2 Robotic-assisted Surgery; 7.3.3.3 Open Surgery; 7.4 Behavioral & Lifestyle Therapy; 7.4.1 Dietary Interventions; 7.4.2 Behavioral Modification Therapy; 7.4.3 Physical Activity Programs; 7.4.4 Psychological Counseling; 7.5 Non-invasive/ Endoscopic Procedures; 7.5.1 Endoscopic Sleeve Gastroplasty (Esg); 7.5.2 Intragastric Balloon (Igb); 7.5.2.1 Orbera Intragastric Balloon; 7.5.2.2 Spatz Adjustable Balloon System; 7.5.3 Aspiration Therapy (Aspireassist); 7.5.4 Transoral Gastroplasty (Toga); 7.6 Medical Devices & Technologies; 7.6.1 Artificial Intelligence & Digital Weight Management Platforms; 7.6.2 Gastric Electrical Stimulation Devices (Maestro System)
8 Europe Obesity Treatment Market, By Age Group: 8.1 Overview; 8.2 Adult Obesity Treatment; 8.3 Geriatric Obesity Treatment; 8.4 Pediatric Obesity Treatment
9 Europe Obesity Treatment Market, By Distribution Channel: 9.1 Overview; 9.2 Online Pharmacies; 9.3 Retail Pharmacies; 9.4 Weight Management Clinics; 9.5 Hospital Pharmacies; 9.6 Wellness & Fitness Centers
10 Europe Obesity Treatment Market, By Patient Type: 10.1 Overview; 10.2 Class Iii; 10.3 Class Ii; 10.4 Class I
11 Europe Obesity Treatment Market, By Region: 11.1 Europe; 11.1.1 United Kingdom; 11.1.2 Germany; 11.1.3 France; 11.1.4 Italy; 11.1.5 Spain; 11.1.6 Russia; 11.1.7 Turkey; 11.1.8 Netherlands; 11.1.9 Switzerland; 11.1.10 Poland; 11.1.11 Ireland; 11.1.12 Austria; 11.1.13 Norway; 11.1.14 Rest Of Europe
12 Europe Obesity Treatment Market, Company Landscape: 12.1 Company Share Analysis: Europe
13 Swot Analysis
14 Company Profile: 14.1 Novo Nordisk A/S; 14.1.1 Company Snapshot; 14.1.2 Revenue Analysis; 14.1.3 Company Share Analysis; 14.1.4 Product Portfolio; 14.1.5 Recent Development; 14.2 Eli Lilly And Company; 14.2.1 Company Snapshot; 14.2.2 Revenue Analysis; 14.2.3 Company Share Analysis; 14.2.4 Product Portfolio; 14.2.5 Recent Development/News; 14.3 Medtronic; 14.3.1 Company Snapshot; 14.3.2 Revenue Analysis; 14.3.3 Company Share Analysis; 14.3.4 Product Portfolio; 14.3.5 Recent Development; 14.4 Boston Scientific Corporation; 14.4.1 Company Snapshots; 14.4.2 Revenue Analysis And Segmented Analysis; 14.4.3 Company Share Analysis; 14.4.4 Product Portfolio; 14.4.5 Recent Development; 14.5 Johnson & Johnson Services, Inc.; 14.5.1 Company Snapshot; 14.5.2 Revenue Analysis; 14.5.3 Company Share Analysis; 14.5.4 Product Portfolio; 14.5.5 Recent Development/News; 14.6 Altimmune; 14.6.1 Company Snapshot; 14.6.2 Pipeline Portfolio; 14.6.3 Recent Updates; 14.7 Astrazeneca; 14.7.1 Company Snapshot; 14.7.2 Revenue Analysis; 14.7.3 Product Portfolio; 14.7.4 Recent Development/News; 14.8 Allurion; 14.8.1 Company Snapshot; 14.8.2 Revenue Analysis; 14.8.3 Product Portfolio; 1.1.5 Recent Development/News; 14.9 Amgen; 14.9.1 Company Snapshot; 14.9.2 Revenue Analysis; 14.9.3 Product Portfolio; 1.1.13 Recent Development/News; 14.10 Arena Pharmaceuticals Ltd; 14.10.1 Company Snapshot; 14.10.2 Product Portfolio; 14.10.3 Recent Development; 14.11 Currax Pharmaceuticals Llc; 14.11.1 Company Snapshot; 14.11.2 Product Portfolio; 14.11.3 Recent Development; 14.12 Cousin Surgery; 14.12.1 Company Snapshot; 14.12.2 Product Portfolio; 14.12.3 Recent Development; 14.13 F. Hoffmann-la Roche Ltd; 14.13.1 Company Snapshot; 14.13.2 Revenue Analysis; 14.13.3 Product Portfolio; 14.13.4 Recent Development/News; 14.14 Fitterfly Healthtech Pvt. Ltd.; 14.14.1 Company Snapshot; 14.14.2 Product Portfolio; 14.14.3 Recent Development; 14.15 Morphic Medical, Inc; 14.15.1 Company Snapshot; 14.15.2 Product Portfolio; 14.15.3 Recent Development; 14.16 Noom, Inc.; 14.16.1 Company Snapshot; 14.16.2 Product Portfolio; 14.16.3 Recent Development; 14.17 Omada Health Inc; 14.17.1 Company Snapshot; 14.17.2 Product Portfolio; 14.17.3 Recent Development; 14.18 Reshape Lifesciences; 14.18.1 Company Snapshot; 14.18.2 Revenue Analysis; 14.18.3 Product Portfolio; 1.1.7 Recent Development/News; 14.19 Raziel; 14.19.1 Company Snapshot; 14.19.2 Product Portfolio; 14.19.3 Recent Development; 14.20 Spatz Fgia Inc.; 14.20.1 Company Snapshot; 14.20.2 Product Portfolio; 14.20.3 Recent Development; 14.21 Sanofi; 14.21.1 Company Snapshot; 14.21.2 Revenue Analysis; 14.21.3 Product Portfolio; 14.21.4 Recent Development; 14.22 Saniona; 14.22.1 Company Snapshot; 14.22.2 Revenue Analysis; 14.22.3 Product Portfolio; 14.22.4 Recent Development; 14.23 Usgi Medical; 14.23.1 Company Snapshot; 14.23.2 Product Portfolio; 14.23.3 Recent Development; 14.24 Vivus Llc.; 14.24.1 Company Snapshot; 14.24.2 Product Portfolio; 14.24.3 Recent Development/News; 14.25 Viking Therapeutics; 14.25.1 Company Snapshots; 14.25.2 Revenue Analysis; 14.25.3 Product Portfolio; 14.25.4 Recent Development; 14.26 Zealand Pharma; 14.26.1 Company Snapshot; 14.26.2 Revenue Analysis; 14.26.3 Product Portfolio; 14.26.4 Recent Development/News
15 Questionnaire
16 Related Reports
List Of Tables: Table 1 Obesity Prevalence By Region (Adults); Table 2 Obesity Prevalence By Gender (Adults); Table 3 Obesity Prevalence By Age (Adults); Table 4 Asia-pacific Clinical Trial Market For Obesity Treatment; Table 5 Distribution Of Products And Projects By Phase Asia-pacific Obesity Treatment Market; Table 6 Distribution Of Projects By Therapeutic Area And Phase Asia-pacific Obesity Treatment Market; Table 7 Asia-pacific Obesity Statistics (2022); Table 8 Asia-pacific Obesity Treatment Market, By Treatment Type, 2018-2032 (Usd Thousand); Table 9 Asia-pacific Pharmacological Treatments (Anti-obesity Drugs) In Obesity Treatment Market, By Region, 2018-2032 (Usd Thousand); Table 10 Asia-pacific Pharmacological Treatment (Anti-obesity Drugs) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 11 Asia-pacific Centrally Acting Anorectics In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 12 Asia-pacific Bariatric Surgery In Obesity Treatment Market, By Region, 2018-2032 (Usd Thousand); Table 13 Asia-pacific Bariatric Surgery In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 14 Asia-pacific Restrictive Surgeries In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 15 Asia-pacific Combination Surgeries In Obesity Treatment Market, By Class, 2018-2032 (Usd Thousand); Table 16 Asia-pacific Bariatric Surgery In Obesity Treatment Market, By Approach, 2018-2032 (Usd Thousand); Table 17 Asia-pacific Behavioral & Lifestyle Therapy In Obesity Treatment Market, By Region, 2018-2032 (Usd Thousand); Table 18 Asia-pacific Behavioral & Lifestyle Therapy In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 19 Asia-pacific Non-invasive/ Endoscopic Procedures In Obesity Treatment Market, By Region, 2018-2032 (Usd Thousand); Table 20 Asia-pacific Non-invasive/ Endoscopic Procedures In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 21 Asia-pacific Intragastric Balloon (Igb) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 22 Asia-pacific Medical Devices & Technologies In Obesity Treatment Market, By Region, 2018-2032 (Usd Thousand); Table 23 Asia-pacific Medical Devices & Technologies In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 24 Asia-pacific Obesity Treatment Market, By Age Group, 2018-2032 (Usd Thousand); Table 25 Asia-pacific Adult Obesity Treatment In Obesity Treatment Market, By Region, 2018-2032 (Usd Thousand); Table 26 Asia-pacific Geriatric Obesity Treatment In Obesity Treatment Market, By Region, 2018-2032 (Usd Thousand); Table 27 Asia-pacific Pediatric Obesity Treatment In Obesity Treatment Market, By Region, 2018-2032 (Usd Thousand); Table 28 Asia-pacific Obesity Treatment Market, By Distribution Channel, 2018-2032 (Usd Thousand); Table 29 Asia-pacific Online Pharmacies In Obesity Treatment Market, By Region, 2018-2032 (Usd Thousand); Table 30 Asia-pacific Retail Pharmacies In Obesity Treatment Market, By Region, 2018-2032 (Usd Thousand); Table 31 Asia-pacific Weight Management Clinics In Obesity Treatment Market, By Region, 2018-2032 (Usd Thousand); Table 32 Asia-pacific Hospital Pharmacies In Obesity Treatment Market, By Region, 2018-2032 (Usd Thousand); Table 33 Asia-pacific Wellness & Fitness Centers In Obesity Treatment Market, By Region, 2018-2032 (Usd Thousand); Table 34 Asia-pacific Obesity Treatment Market, By Patient Type, 2018-2032 (Usd Thousand); Table 35 Asia-pacific Class Iii In Obesity Treatment Market, By Region, 2018-2032 (Usd Thousand); Table 36 Asia-pacific Class Ii In Obesity Treatment Market, By Region, 2018-2032 (Usd Thousand); Table 37 Asia-pacific Class I In Obesity Treatment Market, By Region, 2018-2032 (Usd Thousand); Table 38 Asia- Pacific Obesity Treatment Market, By Country, 2018-2032 (Usd Thousand); Table 39 Asia- Pacific Obesity Treatment Market, By Treatment Type, 2018-2032 (Usd Thousand); Table 40 Asia- Pacific Pharmacological Treatment (Anti-obesity Drugs) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 41 Asia- Pacific Centrally Acting Anorectics In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 42 Asia- Pacific Bariatric Surgery In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 43 Asia- Pacific Restrictive Surgeries In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 44 Asia- Pacific Combination Surgeries In Obesity Treatment Market, By Class, 2018-2032 (Usd Thousand); Table 45 Asia- Pacific Bariatric Surgery In Obesity Treatment Market, By Approach, 2018-2032 (Usd Thousand); Table 46 Asia- Pacific Behavioral & Lifestyle Therapy In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 47 Asia- Pacific Non-invasive/ Endoscopic Procedures In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 48 Asia- Pacific Intragastric Balloon (Igb) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 49 Asia- Pacific Medical Devices & Technologies In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 50 Asia- Pacific Obesity Treatment Market, By Age Group, 2018-2032 (Usd Thousand); Table 51 Asia- Pacific Obesity Treatment Market, By Distribution Channel, 2018-2032 (Usd Thousand); Table 52 Asia- Pacific Obesity Treatment Market, By Patient Type, 2018-2032 (Usd Thousand); Table 53 China Obesity Treatment Market, By Treatment Type, 2018-2032 (Usd Thousand); Table 54 China Pharmacological Treatment (Anti-obesity Drugs) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 55 China Centrally Acting Anorectics In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 56 China Bariatric Surgery In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 57 China Restrictive Surgeries In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 58 China Combination Surgeries In Obesity Treatment Market, By Class, 2018-2032 (Usd Thousand); Table 59 China Bariatric Surgery In Obesity Treatment Market, By Approach, 2018-2032 (Usd Thousand); Table 60 China Behavioral & Lifestyle Therapy In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 61 China Non-invasive/ Endoscopic Procedures In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 62 China Intragastric Balloon (Igb) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 63 China Medical Devices & Technologies In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 64 China Obesity Treatment Market, By Age Group, 2018-2032 (Usd Thousand); Table 65 China Obesity Treatment Market, By Distribution Channel, 2018-2032 (Usd Thousand); Table 66 China Obesity Treatment Market, By Patient Type, 2018-2032 (Usd Thousand); Table 67 Japan Obesity Treatment Market, By Treatment Type, 2018-2032 (Usd Thousand); Table 68 Japan Pharmacological Treatment (Anti-obesity Drugs) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 69 Japan Centrally Acting Anorectics In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 70 Japan Bariatric Surgery In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 71 Japan Restrictive Surgeries In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 72 Japan Combination Surgeries In Obesity Treatment Market, By Class, 2018-2032 (Usd Thousand); Table 73 Japan Bariatric Surgery In Obesity Treatment Market, By Approach, 2018-2032 (Usd Thousand); Table 74 Japan Behavioral & Lifestyle Therapy In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 75 Japan Non-invasive/ Endoscopic Procedures In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 76 Japan Intragastric Balloon (Igb) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 77 Japan Medical Devices & Technologies In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 78 Japan Obesity Treatment Market, By Age Group, 2018-2032 (Usd Thousand); Table 79 Japan Obesity Treatment Market, By Distribution Channel, 2018-2032 (Usd Thousand); Table 80 Japan Obesity Treatment Market, By Patient Type, 2018-2032 (Usd Thousand); Table 81 India Obesity Treatment Market, By Treatment Type, 2018-2032 (Usd Thousand); Table 82 India Pharmacological Treatment (Anti-obesity Drugs) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 83 India Centrally Acting Anorectics In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 84 India Bariatric Surgery In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 85 India Restrictive Surgeries In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 86 India Combination Surgeries In Obesity Treatment Market, By Class, 2018-2032 (Usd Thousand); Table 87 India Bariatric Surgery In Obesity Treatment Market, By Approach, 2018-2032 (Usd Thousand); Table 88 India Behavioral & Lifestyle Therapy In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 89 India Non-invasive/ Endoscopic Procedures In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 90 India Intragastric Balloon (Igb) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 91 India Medical Devices & Technologies In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 92 India Obesity Treatment Market, By Age Group, 2018-2032 (Usd Thousand); Table 93 India Obesity Treatment Market, By Distribution Channel, 2018-2032 (Usd Thousand); Table 94 India Obesity Treatment Market, By Patient Type, 2018-2032 (Usd Thousand); Table 95 Australia Obesity Treatment Market, By Treatment Type, 2018-2032 (Usd Thousand); Table 96 Australia Pharmacological Treatment (Anti-obesity Drugs) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 97 Australia Centrally Acting Anorectics In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 98 Australia Bariatric Surgery In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 99 Australia Restrictive Surgeries In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 100 Australia Combination Surgeries In Obesity Treatment Market, By Class, 2018-2032 (Usd Thousand); Table 101 Australia Bariatric Surgery In Obesity Treatment Market, By Approach, 2018-2032 (Usd Thousand); Table 102 Australia Behavioral & Lifestyle Therapy In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 103 Australia Non-invasive/ Endoscopic Procedures In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 104 Australia Intragastric Balloon (Igb) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 105 Australia Medical Devices & Technologies In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 106 Australia Obesity Treatment Market, By Age Group, 2018-2032 (Usd Thousand); Table 107 Australia Obesity Treatment Market, By Distribution Channel, 2018-2032 (Usd Thousand); Table 108 Australia Obesity Treatment Market, By Patient Type, 2018-2032 (Usd Thousand); Table 109 South Korea Obesity Treatment Market, By Treatment Type, 2018-2032 (Usd Thousand); Table 110 South Korea Pharmacological Treatment (Anti-obesity Drugs) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 111 South Korea Centrally Acting Anorectics In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 112 South Korea Bariatric Surgery In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 113 South Korea Restrictive Surgeries In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 114 South Korea Combination Surgeries In Obesity Treatment Market, By Class, 2018-2032 (Usd Thousand); Table 115 South Korea Bariatric Surgery In Obesity Treatment Market, By Approach, 2018-2032 (Usd Thousand); Table 116 South Korea Behavioral & Lifestyle Therapy In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 117 South Korea Non-invasive/ Endoscopic Procedures In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 118 South Korea Intragastric Balloon (Igb) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 119 South Korea Medical Devices & Technologies In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 120 South Korea Obesity Treatment Market, By Age Group, 2018-2032 (Usd Thousand); Table 121 South Korea Obesity Treatment Market, By Distribution Channel, 2018-2032 (Usd Thousand); Table 122 South Korea Obesity Treatment Market, By Patient Type, 2018-2032 (Usd Thousand); Table 123 Taiwan Obesity Treatment Market, By Treatment Type, 2018-2032 (Usd Thousand); Table 124 Taiwan Pharmacological Treatment (Anti-obesity Drugs) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 125 Taiwan Centrally Acting Anorectics In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 126 Taiwan Bariatric Surgery In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 127 Taiwan Restrictive Surgeries In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 128 Taiwan Combination Surgeries In Obesity Treatment Market, By Class, 2018-2032 (Usd Thousand); Table 129 Taiwan Bariatric Surgery In Obesity Treatment Market, By Approach, 2018-2032 (Usd Thousand); Table 130 Taiwan Behavioral & Lifestyle Therapy In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 131 Taiwan Non-invasive/ Endoscopic Procedures In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 132 Taiwan Intragastric Balloon (Igb) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 133 Taiwan Medical Devices & Technologies In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 134 Taiwan Obesity Treatment Market, By Age Group, 2018-2032 (Usd Thousand); Table 135 Taiwan Obesity Treatment Market, By Distribution Channel, 2018-2032 (Usd Thousand); Table 136 Taiwan Obesity Treatment Market, By Patient Type, 2018-2032 (Usd Thousand); Table 137 Singapore Obesity Treatment Market, By Treatment Type, 2018-2032 (Usd Thousand); Table 138 Singapore Pharmacological Treatment (Anti-obesity Drugs) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 139 Singapore Centrally Acting Anorectics In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 140 Singapore Bariatric Surgery In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 141 Singapore Restrictive Surgeries In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 142 Singapore Combination Surgeries In Obesity Treatment Market, By Class, 2018-2032 (Usd Thousand); Table 143 Singapore Bariatric Surgery In Obesity Treatment Market, By Approach, 2018-2032 (Usd Thousand); Table 144 Singapore Behavioral & Lifestyle Therapy In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 145 Singapore Non-invasive/ Endoscopic Procedures In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 146 Singapore Intragastric Balloon (Igb) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 147 Singapore Medical Devices & Technologies In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 148 Singapore Obesity Treatment Market, By Age Group, 2018-2032 (Usd Thousand); Table 149 Singapore Obesity Treatment Market, By Distribution Channel, 2018-2032 (Usd Thousand)
List Of Figures: Figure 1 Europe Obesity Treatment Market: Segmentation; Figure 2 Europe Obesity Treatment Market: Data Triangulation; Figure 3 Europe Obesity Treatment Market: Droc Analysis; Figure 4 Europe Obesity Treatment Market: Regional Market Analysis; Figure 5 Europe Obesity Treatment Market: Company Research Analysis; Figure 6 Europe Obesity Treatment Market: Lifeline Curve; Figure 7 Europe Obesity Treatment Market: Interview Demographics; Figure 8 Europe Obesity Treatment Market: Dbmr Market Position Grid; Figure 9 Europe Obesity Treatment Market: Market End User Coverage Grid; Figure 10 Europe Obesity Treatment Market: Vendor Share Analysis; Figure 11 Europe Obesity Treatment Market: Segmentation; Figure 12 Europe Obesity Treatment Market Executive Summary; Figure 13 Strategic Decisions; Figure 14 Five Segments Comprise The Europe Obesity Treatment Market , By Treatment Type; Figure 15 Rising Prevalence Of Obesity Is Expected To Drive The Growth Of Europe Obesity Treatment Market From 2025 To 2032; Figure 16 The Pharmacological Treatments (Anti-obesity Drugs) Segment Is Expected To Account For The Largest Share Of The Europe Obesity Treatment Market In 2025 - 2032; Figure 17 Market Overview; Figure 18 Prevalence Of Obesity In Adults Age 20 And Older, By Sex And Age: United States, August 2021–august 2023 Source: Centers For Disease Control And Prevention.; Figure 19 Share Of Pre-obese And Obese Persons Aged 16 Years Or Over, By Sex, 2022 (%); Figure 20 Europe Obesity Treatment Market: By Treatment Type, 2024; Figure 21 Europe Obesity Treatment Market: By Treatment Type, 2025-2032 (Usd Thousand); Figure 22 Europe Obesity Treatment Market: By Treatment Type, Cagr (2025-2032); Figure 23 Europe Obesity Treatment Market: By Treatment Type, Lifeline Curve; Figure 24 Europe Obesity Treatment Market: By Age Group, 2024; Figure 25 Europe Obesity Treatment Market: By Age Group, 2025-2032 (Usd Thousand); Figure 26 Europe Obesity Treatment Market: By Age Group, Cagr (2025-2032); Figure 27 Europe Obesity Treatment Market: By Age Group, Lifeline Curve; Figure 28 Europe Obesity Treatment Market: By Distribution Channel, 2024; Figure 29 Europe Obesity Treatment Market: By Distribution Channel, 2025-2032 (Usd Thousand); Figure 30 Europe Obesity Treatment Market: By Distribution Channel, Cagr (2025-2032); Figure 31 Europe Obesity Treatment Market: By Distribution Channel, Lifeline Curve; Figure 32 Europe Obesity Treatment Market: By Patient Type, 2024; Figure 33 Europe Obesity Treatment Market: By Patient Type, 2025-2032 (Usd Thousand); Figure 34 Europe Obesity Treatment Market: By Patient Type, Cagr (2025-2032); Figure 35 Europe Obesity Treatment Market: By Patient Type, Lifeline Curve; Figure 36 Europe Obesity Treatment Market: Snapshot (2024); Figure 37 Europe Obesity Treatment Market: Company Share 2024 (%)

Pricing

Currency Rates

Single User Email from Publisher $3,500
Global Site License Email from Publisher $4,200

How Do Licenses Work?

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

Chat Now